Considering the fact that p300/CBP mediates the induction of Nox expression in response to pro-inflammatory or diabetic factors, we hypothesized that p300/CBP could become an additional therapeutic target in DKD to attenuate oxidative stress-induced kidney damage. This evidence concerns the gene EP300 and diabetic kidney disease.